Screener
Avantor AVTR VWR Distribution & Services — Net Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Avantor in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Avantor’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 9:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050415
| (in millions) | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| Net sales: | ||||
| Bioscience & Medtech Products | $451.8 | $475.9 | $883.2 | $902.3 |
| VWR Distribution & Services | 1,240.5 | 1,207.5 | 2,390.5 | 2,362.5 |
| Total | $1,692.3 | $1,683.4 | $3,273.7 | $3,264.8 |
| Adjusted Operating Income: | ||||
| Bioscience & Medtech Products | $117.6 | $131.4 | $220.3 | $245.9 |
| VWR Distribution & Services | 126.4 | 141.6 | 231.8 | 289.5 |
| Corporate | (18.9) | (20.8) | (36.4) | (40.4) |
Item 1. Financial statements
FAQ
- What is Avantor's VWR distribution & services — net sales?
- Avantor (AVTR) reported VWR distribution & services — net sales of $1.24B in Q2 2026.
- What does VWR distribution & services — net sales mean?
- This metric represents the total revenue generated from the sale of products and services within the VWR distribution business segment. It reflects the company's ability to monetize its supply chain, laboratory equipment, and specialty procurement offerings to biopharma and industrial customers. Growth in this figure indicates successful market penetration and demand for the segment's portfolio.
Ask your AI about Avantor's vwr distribution & services — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude